Literature DB >> 9779135

Treatment of elevated intracranial pressure by infusions of 10% saline in severely head injured patients.

C Schatzmann1, H E Heissler, K König, P Klinge-Xhemajli, E Rickels, M Mühling, M Börschel, M Samii.   

Abstract

The management of intracranial pressure (ICP) is a factor in outcome of patients with head trauma. However, recent studies have revealed that the current strategies, which have been applied to control ICP for adequate cerebral perfusion, are unsatisfactory. Against this background, the efficacy of short-term infusions of hypertonic saline on ICP was investigated. In severely head injured (SHI) patients, hypertonic saline (100 ml 10% NaCl) was administered when standard agents (mannitol, sorbitol, THAM) failed in reducing ICP. To evaluate the pressure reduction after saline infusions the resulting ICP relaxations were analysed statistically in respect to the parameters amplitude, duration and dynamic behaviour of the ICP responses. In 42 randomized relaxations, the relative ICP decrease was 43% [28%-58%] (median [interquartile range]). The corresponding pressure drop was 18 mmHg [15-27 mm Hg]. Relaxations lasted for 93 min [64-126 min] and a relative ICP minimum was reached 26 min [12-33 min] after infusion. In the individual cases the temporal course of the parameters amplitude and decline interval depict a tendency toward lower and higher values, respectively, under conditions of a generally increasing ICP. As expected, the infusion of hypertonic saline reduces ICP in patients suffering from SHI. The pressure drop, duration and dynamic behaviour are suspected to depend both on the pressure level to reduce and concomitant medications.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9779135     DOI: 10.1007/978-3-7091-6475-4_9

Source DB:  PubMed          Journal:  Acta Neurochir Suppl        ISSN: 0065-1419


  12 in total

Review 1.  Management of intracranial pressure in tuberculous meningitis.

Authors:  J M K Murthy
Journal:  Neurocrit Care       Date:  2005       Impact factor: 3.210

2.  Hypertonic Saline is Superior to Mannitol for the Combined Effect on Intracranial Pressure and Cerebral Perfusion Pressure Burdens in Patients With Severe Traumatic Brain Injury.

Authors:  Halinder S Mangat; Xian Wu; Linda M Gerber; Justin T Schwarz; Malik Fakhar; Santosh B Murthy; Philip E Stieg; Jamshid Ghajar; Roger Härtl
Journal:  Neurosurgery       Date:  2020-02-01       Impact factor: 4.654

Review 3.  Hyperosmolar therapy for intracranial hypertension.

Authors:  Andrew Torre-Healy; Nicholas F Marko; Robert J Weil
Journal:  Neurocrit Care       Date:  2012-08       Impact factor: 3.210

4.  [83/m-Fall on the head : Preparation for the medical specialist examination: part 48].

Authors:  Christoph Linhart; Wolf Mutschler; Tobias Helfen
Journal:  Unfallchirurg       Date:  2021-12       Impact factor: 1.000

Review 5.  Hypertonic saline: a clinical review.

Authors:  R Tyagi; K Donaldson; C M Loftus; J Jallo
Journal:  Neurosurg Rev       Date:  2007-06-16       Impact factor: 3.042

6.  The effects of hypertonic saline and nicotinamide on sensorimotor and cognitive function following cortical contusion injury in the rat.

Authors:  Andrea Quigley; Arlene A Tan; Michael R Hoane
Journal:  Brain Res       Date:  2009-09-23       Impact factor: 3.252

7.  [Diagnosis and treatment of traumatic brain injury].

Authors:  E Rickels
Journal:  Chirurg       Date:  2009-02       Impact factor: 0.955

Review 8.  Contemporary management of traumatic intracranial hypertension: is there a role for therapeutic hypothermia?

Authors:  Matthew Schreckinger; Donald W Marion
Journal:  Neurocrit Care       Date:  2009-12       Impact factor: 3.210

9.  Effects of hypertonic (3%) saline in rats with circulatory shock and cerebral ischemia after heatstroke.

Authors:  Jinn-Rung Kuo; Chia-Li Lin; Chung-Ching Chio; Jhi-Joung Wang; Mao-Tsun Lin
Journal:  Intensive Care Med       Date:  2003-06-19       Impact factor: 17.440

10.  Continuous controlled-infusion of hypertonic saline solution in traumatic brain-injured patients: a 9-year retrospective study.

Authors:  Antoine Roquilly; Pierre Joachim Mahe; Dominique Demeure Dit Latte; Olivier Loutrel; Philippe Champin; Christelle Di Falco; Athanase Courbe; Kevin Buffenoir; Olivier Hamel; Corinne Lejus; Véronique Sebille; Karim Asehnoune
Journal:  Crit Care       Date:  2011-10-28       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.